Cannabis Speaker Call with CB1 Capital’s Todd Harrison on the outlook for 2021
|
CLICK HERE for event details (includes video and materials link) |
Todd is the Founding Partner and the Chief Investment Officer of CB1 Capital. Todd has been on Wall Street for the past three decades and became a student of the cannabis space in the past decade, eventually launching CB1 Capital in 2017.
We will discuss with Todd how the industry is setting up for 2021 following a big run-up in cannabis stocks and the election accelerating the green wave.
Some points of discussion include:
- His experience managing cannabis assets
- Many industry executives believe we are at a point of no return for legalization and that the Biden administration will finally change the investing landscape for cannabis companies. How reasonable is that assumption, and what roadblocks are out there?
- Do cannabis stocks need to pause before they can get another move higher?
Two different CEOs have recently said:
"We've spent more money in DC than anyone and know what's going on. We'll get SAFE banking within six months and likely an amended Cole Memo that'll address fin-cen guidance."
-Boris Jordan, Executive Chairman of Curaleaf (CURLF)
"In terms of the uplisting, we believe strongly that within the next 12 to 24 months, the end of prohibition will have a regulatory framework that will allow for the US senior exchanges to feel comfortable with a listing. If we look, the only leaf touching company on a major exchange is IIPR on the NYSE. The NYSE got comfortable with IIPR because of the Cole Memo. When the Cole Memo was rescinded, both NASDAQ and the NYSE stood down on listing additional names involved in the cannabis industry. We are fairly confident that the new Attorney General will come out with similar guidance under the Biden administration pretty quickly after taking office in January of 2021. So we anticipate being able to list on the US exchange in the next calendar year."
-Michael Auerbach, Founder, and Chairman of Subversive Capital Acquisition Corp. (SBVCF)
- Will an amended Cole Memo enable companies to be uplisted, and will more institutions be permitted to invest in cannabis? Or do we need cannabis to be de-scheduled for this to happen?
- How should we think about Cannabis 3.0 when prohibition is lifted, and how should investors consider issues like interstate commerce?
And so much more! As always, if you have any questions, please email , and we will ask Todd!
